2. CSR Pillars

Our CSR strategy is structured around four core pillars:

2.1 Access to Affordable & Essential Medicines

Panamfarma is committed to improving access to high-quality, life-saving medicines, especially for vulnerable populations.

• Partnerships with local and international health organizationsto provide affordable pharmaceuticals.
• Donation and subsidy programsfor essential medications in underprivileged communities.
• Support for government and NGO healthcare initiativesaimed at eradicating preventable diseases.
• Import and distribution of biosimilarsto enhance affordability and accessibility of critical therapies.

2.2 Ethical Business & Compliance Practices

Maintaining the highest ethical and regulatory standards in pharmaceutical distribution and supply.

• Full compliance with WHO, COFEPRIS, and international regulatory guidelines.
• Transparency and anti-corruption policiesin all business operations.
• Ethical sourcing and supply chain integrityto ensure fair trade practices.
• Whistleblower and compliance mechanismsfor reporting unethical activities.

2.3 Environmental Sustainability & Green Initiatives

Reducing our environmental footprint through sustainable practices.

• Eco-friendly pharmaceutical logistics, including responsible waste disposal and carbon footprint reduction in transportation.
• Recyclable and biodegradable packaging solutionsfor product shipments.
• Energy-efficient storage facilitieswith temperature-controlled solutions to reduce power consumption.
• Participation in global climate action programswithin the pharmaceutical industry.

2.4 Community Engagement & Health Education

Empowering communities through education and healthcare awareness.

• Public health campaignson disease prevention, vaccination, and medication adherence.
• Educational workshops for healthcare professionalson the latest advancements in pharmaceuticals and biosimilars.
• Scholarship and internship programsfor students in the pharmaceutical and healthcare fields.
• Collaboration with universities and research institutionsfor advancing pharmaceutical science.

3. CSR Implementation & Impact Measurement

To ensure the effectiveness of our CSR initiatives, Panamfarma employs a structured implementation and monitoring process:

• Annual CSR budget allocationto fund community projects and sustainability efforts.
• Partnerships with NGOs, hospitals, and government agenciesto amplify social impact.
• Regular audits and impact assessmentsto measure the effectiveness of our programs.
• Publication of an annual CSR reportto maintain transparency with stakeholders.

4. CSR Partnerships & Collaborations

Panamfarma actively collaborates with key stakeholders, including:

• World Health Organization (WHO)for healthcare initiatives.
• Government health departments and COFEPRISfor regulatory compliance and public health programs.
• Universities and research institutionsfor R&D and student training programs.
• Environmental organizationsfor sustainability and green initiatives.

5. Commitment to Long-Term Social Responsibility

Panamfarma remains committed to continuous improvement in its CSR efforts by:

• Expanding outreach programsin Latin America to enhance healthcare accessibility.
• Investing in new technologiesfor sustainable and ethical pharmaceutical distribution.
• Strengthening community partnershipsto promote long-term health and well-being.

This Corporate Social Responsibility (CSR) Program reflects our unwavering commitment to ethical business practices, sustainability, and social impact in the pharmaceutical industry.